User profiles for AA Roger Thompson

AA Roger Thompson

University of Sheffield
Verified email at sheffield.ac.uk
Cited by 6286

[PDF][PDF] SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses

…, Z Takats, P Takis, RS Tedder, AAR Thompson… - Cell, 2022 - cell.com
On 24 th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529
was announced, containing far more mutations in Spike (S) than previously reported …

[HTML][HTML] Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP …

…, RS Tedder, EC Thomson, AAR Thompson… - The Lancet …, 2021 - thelancet.com
Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …

MET is required for the recruitment of anti-tumoural neutrophils

…, M Di Matteo, J Serneels, S Costa, AAR Thompson… - Nature, 2015 - nature.com
Mutations or amplification of the MET proto-oncogene are involved in the pathogenesis of
several tumours 1 , 2 , 3 , 4 , which rely on the constitutive engagement of this pathway for their …

[HTML][HTML] Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

…, RS Tedder, EC Thomson, AAR Thompson… - The Lancet …, 2021 - thelancet.com
Background Prognostic models to predict the risk of clinical deterioration in acute COVID-19
cases are urgently required to inform clinical management decisions. Methods We …

[HTML][HTML] Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective …

…, L Norman, CA Shaw, KA McLean, AAR Thompson… - The Lancet, 2021 - thelancet.com
Background COVID-19 is a multisystem disease and patients who survive might have in-hospital
complications. These complications are likely to have important short-term and long-…

[HTML][HTML] Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort …

…, RS Tedder, EC Thomson, AAR Thompson… - The Lancet …, 2021 - thelancet.com
Background Studies of patients admitted to hospital with COVID-19 have found varying
mortality outcomes associated with underlying respiratory conditions and inhaled corticosteroid …

[HTML][HTML] SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

…, N Mohamed, J Nunag, C King, AAR Thompson… - …, 2023 - thelancet.com
Background Most studies of immunity to SARS-CoV-2 focus on circulating antibody, giving
limited insights into mucosal defences that prevent viral replication and onward transmission. …

Targeting vascular remodeling to treat pulmonary arterial hypertension

AAR Thompson, A Lawrie - Trends in molecular medicine, 2017 - cell.com
Pulmonary arterial hypertension (PAH) describes a group of conditions with a common
hemodynamic phenotype of increased pulmonary artery pressure, driven by progressive …

Mechanical activation of hypoxia-inducible factor 1α drives endothelial dysfunction at atheroprone sites

…, BT Ayllon, S Akhtar, AAR Thompson… - … , and vascular biology, 2017 - Am Heart Assoc
Objective— Atherosclerosis develops near branches and bends of arteries that are exposed
to low shear stress (mechanical drag). These sites are characterized by excessive …

[PDF][PDF] Neutrophils fuel effective immune responses through gluconeogenesis and glycogenesis

…, CJ Graham, JP Thomson, K Baillie, AAR Thompson… - Cell metabolism, 2021 - cell.com
Neutrophils can function and survive in injured and infected tissues, where oxygen and
metabolic substrates are limited. Using radioactive flux assays and LC-MS tracing with U- 13 C …